Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

HLSE:RAIVV
HLSE:RAIVVFood

Raisio (HLSE:RAIVV) Margin Improvement Reinforces Bullish Earnings Narratives

Raisio (HLSE:RAIVV) has wrapped up FY 2025 with fourth quarter revenue of €55.2 million and EPS of €0.03, capping a twelve month period where trailing revenue was €224.2 million and EPS reached €0.146836, alongside year over year net earnings growth of 37.3%. Over the last six reported quarters, the company has seen quarterly revenue move between €54.5 million and €59.1 million, while quarterly EPS ranged from €0.02 to €0.05, providing a clearer picture of how the current run rate compares...
ENXTAM:ABN
ENXTAM:ABNBanks

ABN AMRO Bank (ENXTAM:ABN) Q4 Cost To Income Spike Tests Bullish Margin Narratives

ABN AMRO Bank (ENXTAM:ABN) has wrapped up FY 2025 with fourth quarter revenue of €2.2 billion and basic EPS of €0.44, alongside trailing 12 month revenue of €8.7 billion and EPS of €2.71 that frame the latest print in a fuller earnings picture. Over recent quarters, the bank has seen quarterly revenue move between €2.1 billion and €2.3 billion while EPS has ranged from €0.33 to €0.99, giving investors a clear view of how profitability per share has tracked against a relatively steady top...
BIT:BGN
BIT:BGNCapital Markets

Banca Generali (BIT:BGN) Margin Slippage Challenges Bullish High‑Profitability Narrative

How Banca Generali (BIT:BGN) just performed Banca Generali (BIT:BGN) has closed FY 2025 with fourth quarter total revenue of €276.6 million and basic EPS of €1.15, alongside trailing twelve month revenue of €994.1 million and EPS of €3.91. This gives investors a clear snapshot of its recent earnings power. Over the past few quarters, the bank has reported revenue of €222.0 million in Q3 2024 with EPS of €0.87, followed by €241.3 million in Q3 2025 with EPS of €1.00, and then another step up...
NYSE:DRD
NYSE:DRDMetals and Mining

Is DRDGOLD’s (DRD) Sector Tailwind Highlighting Durable Strength or Masking Company-Specific Challenges?

In early February 2026, DRDGOLD drew fresh attention as its recent performance was highlighted alongside stronger results from other gold miners, reinforcing perceptions of improved business outcomes. The company’s inclusion among peers benefiting from a healthier gold mining backdrop has reinforced its position as a potentially resilient sector participant. We’ll now examine how DRDGOLD’s favorable positioning within a strengthening gold mining sector shapes the company’s investment...
TSX:IFC
TSX:IFCInsurance

How Investors May Respond To Intact Financial (TSX:IFC) Dividend Hike And New Share Buyback Program

In February 2026, Intact Financial Corporation reported full-year 2025 net income of CA$3.37 billion, boosted earnings per share from continuing operations, raised its common-share dividend to CA$1.47, declared dividends across several preferred share series, and authorized a new 12‑month share repurchase program for up to 3% of its outstanding shares. An interesting aspect of this announcement is that the CA$0.14 quarterly dividend increase marks Intact’s 21st consecutive annual...
XTRA:MRK
XTRA:MRKPharmaceuticals

Merck KGaA Electronics Leadership Shift And What It Means For Investors

Merck KGaA (XTRA:MRK) has appointed Benjamin Hein as chief executive of its Electronics business and member of the executive board. Hein succeeds Kai Beckmann, who has moved into the role of overall CEO of Merck KGaA. The leadership changes affect the group’s Electronics segment, a core supplier of materials for the semiconductor industry. The Electronics business sits at the heart of Merck KGaA’s role as a supplier to chipmakers, display manufacturers and other high tech end markets. For...
NYSE:CE
NYSE:CEChemicals

Is Celanese (CE) Using Dividend And Price Hikes To Quietly Recast Its Margin Strategy?

Celanese Corporation recently declared a quarterly cash dividend of US$0.03 per share on its common stock, payable on March 10, 2026 to shareholders of record as of February 24, 2026, and earlier this week raised prices for acetic acid, vinyl acetate monomer and related derivatives in the Western Hemisphere. This combination of a modest cash return to shareholders and immediate pricing actions in key chemical products underscores management’s focus on margin protection amid cautious earnings...
NYSEAM:JMG
NYSEAM:JMGRetail Distributors

JM Group (HKEX:JMG) Earnings Growth Driven By Non Cash Margin Raises Questions For Bulls

JM Group (JMG) has put fresh numbers on the table for FY 2025, with second half revenue of HK$122.0 million and basic EPS of HK$0.39, while the trailing twelve months show revenue of HK$269.4 million and EPS of HK$1.17 backed by net income of HK$18.7 million. The company has seen revenue move from HK$92.1 million and EPS of HK$0.12 in 2H 2024 to HK$147.3 million and EPS of HK$0.78 in 1H 2025, before landing at the latest half year figures. Over the past year, earnings growth of 165.4% has...
TSE:8591
TSE:8591Diversified Financial

Assessing ORIX (TSE:8591) Valuation After Record Earnings And Expanded Share Buyback

ORIX (TSE:8591) is back in focus after reporting record-high net income and solid revenue for the nine months to December 31, 2025, alongside an expanded share buyback and a steady full year outlook. See our latest analysis for ORIX. The earnings beat and expanded buyback have coincided with a sharp rebound in sentiment, with a 90-day share price return of 39.09% and a 1-year total shareholder return of 85.79%. This indicates that momentum has picked up meaningfully after a strong recent...
WBAG:BG
WBAG:BGBanks

BAWAG Group (WBAG:BG) Margin Compression Tests Bullish Earnings Growth Narrative

BAWAG Group (WBAG:BG) has wrapped up FY 2025 with fourth quarter revenue of €511.6 million and basic EPS of €2.99, capping off a trailing twelve month run that produced €1.99 billion in revenue and EPS of €11.17. The bank has seen revenue move from €1.51 billion and EPS of €9.40 over the trailing period ending Q4 2024 to €1.99 billion and EPS of €11.17 by Q4 2025, with net income over the same window rising from €738.0 million to €859.9 million. With a current share price of €133.50, these...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Is Cognex (CGNX) Fairly Priced After Recent Share Price Recovery?

If you are wondering whether Cognex is fairly priced or if there is still value left on the table, this article is designed to walk you through that question in a clear, practical way. Cognex shares last closed at US$43.03, with returns of 5.6% over 7 days, 9.1% over 30 days, 16.5% year to date and 10.6% over 1 year, set against longer term returns of a 21.9% decline over 3 years and a 49.1% decline over 5 years that some investors may still have in mind. Recent coverage around Cognex has...
NasdaqGS:TXRH
NasdaqGS:TXRHHospitality

Assessing Texas Roadhouse (TXRH) Valuation As Momentum Cools After Multi Year Shareholder Gains

Why Texas Roadhouse stock is on investors’ radar Texas Roadhouse (TXRH) has attracted fresh attention after recent share price moves, with the stock posting mixed short term returns alongside stronger performance over the past 3 years and 5 years. See our latest analysis for Texas Roadhouse. At a share price of US$183.37, Texas Roadhouse’s recent 30 day share price return of a 2.48% decline contrasts with its 90 day gain of 9.08% and a 5 year total shareholder return of 134.66%. This...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Expands Beyond Cystic Fibrosis With WuXi Autoimmune Alliance

Vertex Pharmaceuticals (NasdaqGS:VRTX) has entered an exclusive license and collaboration with WuXi Biologics to develop a trispecific T-cell Engager for B-cell mediated autoimmune diseases. The agreement focuses on a novel immunotherapy approach that aims to redirect T cells toward B cells involved in autoimmune activity. The partnership expands Vertex's pipeline beyond cystic fibrosis and gene editing into autoimmune indications that can represent large treatment markets. For you as an...
NYSE:SCHW
NYSE:SCHWCapital Markets

Charles Schwab Confronts AI Wealth Management Threats While Shares Look Undervalued

Altruist has launched an AI powered tax planning tool, raising questions about how traditional wealth managers will compete. The launch contributed to a broad selloff in financial services stocks as investors reassessed technology risks and opportunities. Charles Schwab (NYSE:SCHW) responded through its CEO, who highlighted Schwab's existing investments in AI and how the firm is using the technology across its operations. For you as an investor, this story is about how Charles Schwab fits...
NYSE:AWK
NYSE:AWKWater Utilities

Is American Water Works Company (AWK) Pricing Reflect Long‑Term Returns After Recent Share Weakness

If you are wondering whether American Water Works Company is fairly priced or not, this article will walk you through what its current share price might be implying about value. The stock recently closed at US$123.69, with returns of a 0.5% decline over 7 days, a 5.1% decline over 30 days, a 5.1% decline year to date, a 1.4% gain over 1 year, an 11.2% decline over 3 years and a 14.9% decline over 5 years. Recent moves in the share price have kept investor attention on how a regulated water...
BIT:REY
BIT:REYIT

Reply’s Oncology Biobank Move Meets Weak Share Price And Valuation Debate

Laife Reply, a subsidiary of Reply, has partnered with the European Institute of Oncology to launch Italy's first AI based digital biobank integrated into real world clinical diagnostics. The platform applies AI and Big Data techniques to support cancer diagnostics within a live clinical setting. The initiative positions Reply at the forefront of AI supported medicine in Italy's healthcare sector. For investors watching Reply (BIT:REY), this move ties a concrete healthcare project to a...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Is Fiserv’s Earnings Beat and INDX Launch Altering The Investment Case For Fiserv (FISV)?

Fiserv, Inc. recently reported fourth-quarter 2025 results with revenue of US$5,284 million and net income of US$811 million, beating profit expectations but pairing that with cautious 2026 guidance and ongoing cost pressures under its “One Fiserv” transformation plan. At the same time, Fiserv launched INDX, a real-time cash settlement platform that keeps client funds off-chain while offering up to US$25 million of FDIC insurance per custodial account, highlighting how the company is trying...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

Assessing Flex (FLEX) Valuation After Raised Guidance And Data Center Growth Focus

Why Flex’s updated guidance is drawing fresh attention Flex (FLEX) recently raised its full year net sales guidance and highlighted improved margins tied to data center and technology solutions. This move has coincided with positive earnings estimate revisions and stronger investor interest. See our latest analysis for Flex. That updated guidance and the focus on data center and industrial solutions have come alongside building momentum in the shares, with a 7.81% 7 day share price return and...
BIT:RACE
BIT:RACEAuto

Ferrari (BIT:RACE) Margins Hold Above 22% Challenging Bullish Expansion Narratives

Ferrari (BIT:RACE) has wrapped up FY 2025 with fourth quarter revenue of about €1.8 billion and basic EPS of €2.14, rounding out a trailing twelve month picture that includes €7.1 billion in revenue and EPS of €8.97. Over recent quarters, the company has seen revenue move from €1.64 billion in Q3 2024 to €1.74 billion in Q4 2024 and then to €1.80 billion in Q4 2025, while quarterly EPS has tracked in a tight range between €2.08 and €2.38. With trailing net profit margins holding in the low...
ENXTBR:ECONB
ENXTBR:ECONBIT

Econocom Group (ENXTBR:ECONB) Margin Improvement To 1.8% Tests Pessimistic Earnings Narrative

Econocom Group (ENXTBR:ECONB) closed FY 2025 with second half revenue of €1.5b and net income from continuing operations of €34.5m, while trailing twelve month net income from continuing operations reached €53.2m. The company has seen half year revenue move from €1.4b in H2 2024 to €1.5b in H2 2025, with trailing twelve month revenue rising from €2.7b to €2.9b over the same comparison window. With net profit margins running at 1.8% over the last year and earnings growth expectations in focus,...
ENXTPA:RXL
ENXTPA:RXLTrade Distributors

Rexel (ENXTPA:RXL) Margin Compression To 1.3% Tests Bullish Electrification Narratives

Rexel (ENXTPA:RXL) has reported its FY 2025 results with first half revenue of €9.8b and basic EPS of €0.88, setting the tone for how investors are reading the year alongside the current share price of €37.67. The company has seen revenue move from €9.6b in the first half of 2024 to €9.8b in the first half of 2025, while basic EPS shifted from €1.17 to €0.88 over the same periods. This gives investors a clear view of how the top line and per share earnings are tracking as margins come under...
ASX:ORA
ASX:ORAPackaging

Orora (ASX:ORA) Margin Lift To 5.7% Tests Valuation Narratives After One Off Loss

Financial results set the stage for Orora (ASX:ORA) Orora (ASX:ORA) has put fresh H1 2026 numbers on the table, with total revenue of A$1,061.9 million and basic EPS of A$0.050, setting a clear reference point after a period that also featured earnings from discontinued operations and one off items in prior periods. The company has seen revenue move from A$1,055.7 million in H2 2024 to A$1,028.3 million in H1 2025 and then A$1,061.9 million in H2 2025, while EPS shifted from A$0.054 to...